DK0551729T3 - gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterier - Google Patents
gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterierInfo
- Publication number
- DK0551729T3 DK0551729T3 DK92310807.0T DK92310807T DK0551729T3 DK 0551729 T3 DK0551729 T3 DK 0551729T3 DK 92310807 T DK92310807 T DK 92310807T DK 0551729 T3 DK0551729 T3 DK 0551729T3
- Authority
- DK
- Denmark
- Prior art keywords
- medicament
- gamma
- linolenic acid
- manufacture
- preventing arterial
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 title abstract 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 title abstract 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 title abstract 2
- 229960002733 gamolenic acid Drugs 0.000 title abstract 2
- 206010038563 Reocclusion Diseases 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 1
- 210000004351 coronary vessel Anatomy 0.000 abstract 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Control Of Turbines (AREA)
- Amplifiers (AREA)
- Glass Compositions (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Semiconductor Lasers (AREA)
- Drying Of Semiconductors (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919125602A GB9125602D0 (en) | 1991-12-02 | 1991-12-02 | Method of preventing reocclusion of arteries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0551729T3 true DK0551729T3 (da) | 1996-02-12 |
Family
ID=10705559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92310807.0T DK0551729T3 (da) | 1991-12-02 | 1992-11-26 | gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterier |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5378732A (enExample) |
| EP (2) | EP0676197A3 (enExample) |
| JP (1) | JPH05286854A (enExample) |
| KR (1) | KR930012009A (enExample) |
| AT (1) | ATE133334T1 (enExample) |
| AU (2) | AU657009B2 (enExample) |
| CA (1) | CA2084273A1 (enExample) |
| DE (1) | DE69207885T2 (enExample) |
| DK (1) | DK0551729T3 (enExample) |
| ES (1) | ES2082390T3 (enExample) |
| GB (1) | GB9125602D0 (enExample) |
| GR (1) | GR3019270T3 (enExample) |
| HK (1) | HK131096A (enExample) |
| NO (1) | NO303047B1 (enExample) |
| NZ (1) | NZ245343A (enExample) |
| TW (1) | TW223589B (enExample) |
| ZA (1) | ZA929316B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824644A (en) * | 1994-07-07 | 1998-10-20 | G. D. Searle & Co. | Method of attenuating arterial stenosis |
| GB0016045D0 (en) * | 2000-06-29 | 2000-08-23 | Laxdale Limited | Therapeutic combinations of fatty acids |
| JP2002047176A (ja) * | 2000-08-04 | 2002-02-12 | Idemitsu Technofine Co Ltd | ＩｇＥ産生抑制剤 |
| ITMI20012384A1 (it) * | 2001-11-12 | 2003-05-12 | Quatex Nv | Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori |
| US7098352B2 (en) * | 2001-11-16 | 2006-08-29 | Virtus Nutrition Llc | Calcium salt saponification of polyunsaturated oils |
| CA2436650A1 (en) * | 2003-08-06 | 2005-02-06 | Naturia Inc. | Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses |
| EA200602014A1 (ru) * | 2004-04-30 | 2007-08-31 | ВИРТУС НЬЮТРИШН ЭлЭлСи | Синтез солей одновалентных и двухвалентных металлов полиненасыщенных жирных кислот |
| CA2675836C (en) * | 2007-01-17 | 2016-10-11 | Mochida Pharmaceutical Co., Ltd. | Composition for preventing or treating thrombus- or embolus-associated disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1240513A (en) * | 1968-09-13 | 1971-07-28 | Ono Pharmaceutical Co | Poly-unsaturated fatty acid ester composition and its preparation |
| GB1580444A (en) * | 1976-11-04 | 1980-12-03 | Bio Oil Res | Pharmaceutical compositions |
| US4526902A (en) * | 1983-10-24 | 1985-07-02 | Century Laboratories, Inc. | Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions |
| JPS60132916A (ja) * | 1983-12-21 | 1985-07-16 | Nisshin Oil Mills Ltd:The | 血栓症予防食品または医薬品 |
| IT1176916B (it) * | 1984-10-10 | 1987-08-18 | Elvira Pistolesi | Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica |
| US4920098A (en) * | 1986-09-17 | 1990-04-24 | Baxter International Inc. | Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases |
| US5059622A (en) * | 1989-08-29 | 1991-10-22 | Biosyn, Inc. | Method for reducing blood pressure levels in hypertensive persons |
| GB8916734D0 (en) * | 1989-07-21 | 1989-09-06 | Efamol Holdings | Pharmaceutical and dietary uses of fatty acids |
-
1991
- 1991-12-02 GB GB919125602A patent/GB9125602D0/en active Pending
-
1992
- 1992-11-25 US US07/981,116 patent/US5378732A/en not_active Expired - Fee Related
- 1992-11-26 AT AT92310807T patent/ATE133334T1/de not_active IP Right Cessation
- 1992-11-26 ES ES92310807T patent/ES2082390T3/es not_active Expired - Lifetime
- 1992-11-26 DK DK92310807.0T patent/DK0551729T3/da active
- 1992-11-26 EP EP95201322A patent/EP0676197A3/en not_active Withdrawn
- 1992-11-26 EP EP92310807A patent/EP0551729B1/en not_active Expired - Lifetime
- 1992-11-26 DE DE69207885T patent/DE69207885T2/de not_active Expired - Fee Related
- 1992-11-27 AU AU29687/92A patent/AU657009B2/en not_active Ceased
- 1992-12-01 NO NO924637A patent/NO303047B1/no unknown
- 1992-12-01 CA CA002084273A patent/CA2084273A1/en not_active Abandoned
- 1992-12-01 ZA ZA929316A patent/ZA929316B/xx unknown
- 1992-12-01 JP JP4321904A patent/JPH05286854A/ja active Pending
- 1992-12-02 KR KR1019920023149A patent/KR930012009A/ko not_active Ceased
- 1992-12-02 NZ NZ245343A patent/NZ245343A/en unknown
- 1992-12-07 TW TW081109770A patent/TW223589B/zh active
-
1995
- 1995-04-19 AU AU16563/95A patent/AU680725B2/en not_active Ceased
- 1995-11-14 US US08/557,545 patent/US5859055A/en not_active Expired - Fee Related
-
1996
- 1996-03-12 GR GR960400672T patent/GR3019270T3/el unknown
- 1996-07-18 HK HK131096A patent/HK131096A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GR3019270T3 (en) | 1996-06-30 |
| US5859055A (en) | 1999-01-12 |
| EP0676197A2 (en) | 1995-10-11 |
| TW223589B (enExample) | 1994-05-11 |
| AU680725B2 (en) | 1997-08-07 |
| US5378732A (en) | 1995-01-03 |
| EP0551729B1 (en) | 1996-01-24 |
| NZ245343A (en) | 1997-06-24 |
| AU1656395A (en) | 1995-06-29 |
| NO924637D0 (no) | 1992-12-01 |
| ES2082390T3 (es) | 1996-03-16 |
| AU2968792A (en) | 1993-06-03 |
| CA2084273A1 (en) | 1993-06-03 |
| DE69207885T2 (de) | 1996-07-25 |
| JPH05286854A (ja) | 1993-11-02 |
| KR930012009A (ko) | 1993-07-20 |
| ATE133334T1 (de) | 1996-02-15 |
| NO303047B1 (no) | 1998-05-25 |
| HK131096A (en) | 1996-07-26 |
| EP0676197A3 (en) | 1996-09-11 |
| GB9125602D0 (en) | 1992-01-29 |
| DE69207885D1 (de) | 1996-03-07 |
| AU657009B2 (en) | 1995-02-23 |
| EP0551729A1 (en) | 1993-07-21 |
| ZA929316B (en) | 1993-09-09 |
| NO924637L (no) | 1993-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU562938B2 (en) | 7, 10, 13, 16 docosatetraenoic acid composition | |
| DE3669103D1 (de) | Ibuprofen enthaltendes arzneimittel. | |
| DE68923819D1 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
| SE8803472D0 (sv) | Anvaendning av gamma-interferon foer behandling av vaskulaer stenos | |
| GB8918294D0 (en) | Pharmaceutical compositions | |
| FI940659A0 (fi) | Heterosyklisesti substituoituja fenyylisykloheksaanikarboksyylihappojohdannaisia | |
| DE69202019D1 (de) | Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS. | |
| DE3875286D1 (de) | Essentielle fettsaeure enthaltende zusammensetzungen. | |
| ATE43242T1 (de) | Pharmazeutische oder diaetetische zusammensetzung mit hoher antithrombotischer und antiarteriosklerotischer wirkung. | |
| DK0458287T3 (da) | Anvendelse af magnesium-pyridoxal-5-phosphat-glutaminat til forebyggelse af sygdomme forårsaget af vaskulære læsioner | |
| DK399288A (da) | Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion | |
| NO924637L (no) | Fremgangsmaate ved forhindring av gjentilstopping av arterier | |
| DE68912432D1 (de) | Pharmazeutische Zusammensetzung, verwendbar bei der Behandlung von Herzgefässerkrankungen. | |
| DK417889A (da) | Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme | |
| FR2689402B1 (fr) | Introducteur vasculaire percutane pour alimentation d'un circuit sanguin extracorporel. | |
| IT212830Z2 (it) | Giuoco da tavolo basato sull'ominimia delle parole | |
| DE69021980D1 (de) | Castanosperminester zur Behandlung der zerebralen Malaria. | |
| DK448289D0 (da) | Kombineret behandling af arteria femoralis superficialis okklusion med perkutan transluminal angioplastik og lokalt indelukket rekombineret plasminogen aktivator 4 lumen eller flere lumina med 2 ellerflere balloner paa kateteret | |
| CS719388A1 (en) | Derivatives of thioallophanic acid |